BE870988A - Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium - Google Patents

Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium

Info

Publication number
BE870988A
BE870988A BE190889A BE190889A BE870988A BE 870988 A BE870988 A BE 870988A BE 190889 A BE190889 A BE 190889A BE 190889 A BE190889 A BE 190889A BE 870988 A BE870988 A BE 870988A
Authority
BE
Belgium
Prior art keywords
pharmaceutical composition
composition containing
potassium clavulanate
containing amoxycillin
amoxycillin
Prior art date
Application number
BE190889A
Other languages
English (en)
French (fr)
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE870988(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of BE870988A publication Critical patent/BE870988A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE190889A 1977-10-11 1978-10-03 Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium BE870988A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
BE870988A true BE870988A (fr) 1979-04-03

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
BE190889A BE870988A (fr) 1977-10-11 1978-10-03 Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium

Country Status (24)

Country Link
US (2) US4441609A (xx)
JP (1) JPS5476831A (xx)
AU (1) AU525089B2 (xx)
BE (1) BE870988A (xx)
CA (1) CA1105385A (xx)
CH (1) CH642258A5 (xx)
DE (1) DE2843318A1 (xx)
FR (1) FR2405711A1 (xx)
GB (1) GB2005538B (xx)
HK (1) HK73785A (xx)
IE (1) IE47450B1 (xx)
IL (1) IL55660A (xx)
IT (1) IT1109273B (xx)
JO (1) JO984B1 (xx)
KE (1) KE3525A (xx)
MT (1) MTP836B (xx)
MY (1) MY8500996A (xx)
NL (1) NL190631B (xx)
NZ (1) NZ188497A (xx)
PL (1) PL210174A1 (xx)
PT (1) PT68600A (xx)
SE (2) SE435899B (xx)
SG (1) SG34985G (xx)
ZA (1) ZA785682B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440462B1 (en) 1996-03-13 2002-08-27 Biochemie Gesellschaft M.B.H. Agglomerates of β-lactam antibiotics and processess for making agglomerates

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
YU40452B (en) * 1975-02-07 1986-02-28 Beecham Group Plc Process for the elimination of contaminating impurities from clavulinic acid
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ194912A (en) 1979-10-02 1983-05-31 Beecham Group Ltd 6 -(2-(2'-methylphenoxycarbonyl)-2-thien-3'-ylacetamido)-penicillanic acid and pharmaceutical compositions
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (fr) * 1986-01-22 1988-12-23 Adir Conditionnement etanche sous forme de plaquettes alveolaire permettant des echanges gazeux entre les alveoles.
DE3776116D1 (de) * 1986-12-30 1992-02-27 American Cyanamid Co Zusammensetzung die ein polycarbophil enthaelt.
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
NZ291443A (en) * 1994-08-05 1998-07-28 Smithkline Beecham Plc Container with puncturable seal carrying desiccant polymer
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
EP1147771A1 (en) 1995-09-07 2001-10-24 Smithkline Beecham Corporation Pharmaceutical formulation containing amoxycillin and clavulanate
AT403375B (de) * 1995-11-15 1998-01-26 Biochemie Gmbh Verfahren zur fällung von alkalisalzen der clavulansäure
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
ID23673A (id) * 1997-02-14 2000-05-11 Smithkline Beecham Lab Pharma Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
AU1232500A (en) * 1998-10-30 2000-05-22 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
AU781218B2 (en) * 1999-08-16 2005-05-12 Revaax Pharmaceuticals, Llc Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases
SI20411A (sl) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Vodotopni praški za peroralno raztopino in njihova uporaba
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US20060039967A1 (en) * 2002-08-12 2006-02-23 Motohiro Ohta Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
EP2175999B1 (en) 2007-06-21 2017-01-04 Gen-Probe Incorporated Receptacles for use in performing processes
WO2009055038A1 (en) 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
BRPI1013901A2 (pt) * 2009-04-29 2019-09-24 Rexahn Pharmaceuticals Inc formulação de clavulanato para neuroproteção e tratamento de distúrbios neurodegenerativos
TR200909787A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Üçüncü kuşak bir sefalosporin ve klavulanik asit içeren farmasötik formülasyonlar.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440462B1 (en) 1996-03-13 2002-08-27 Biochemie Gesellschaft M.B.H. Agglomerates of β-lactam antibiotics and processess for making agglomerates

Also Published As

Publication number Publication date
IL55660A0 (en) 1978-12-17
IT1109273B (it) 1985-12-16
MTP836B (en) 1979-05-11
KE3525A (en) 1985-05-31
JPS6341886B2 (xx) 1988-08-19
SE435899B (sv) 1984-10-29
FR2405711B1 (xx) 1982-10-29
HK73785A (en) 1985-10-04
SE451668B (sv) 1987-10-26
JPS5476831A (en) 1979-06-19
MY8500996A (en) 1985-12-31
US4301149A (en) 1981-11-17
US4441609A (en) 1984-04-10
GB2005538A (en) 1979-04-25
AU525089B2 (en) 1982-10-21
SG34985G (en) 1985-11-15
NZ188497A (en) 1981-05-01
IE47450B1 (en) 1984-03-21
NL7810176A (nl) 1979-04-17
PT68600A (en) 1978-10-01
SE8107592L (sv) 1981-12-17
CH642258A5 (de) 1984-04-13
SE7810591L (sv) 1979-04-12
FR2405711A1 (fr) 1979-05-11
JO984B1 (en) 1979-12-01
IL55660A (en) 1981-09-13
IT7851415A0 (it) 1978-10-09
DE2843318A1 (de) 1979-04-12
GB2005538B (en) 1982-05-26
CA1105385A (en) 1981-07-21
AU4050678A (en) 1980-04-17
NL190631B (nl) 1994-01-03
IE782019L (en) 1979-04-11
PL210174A1 (xx) 1980-08-11
ZA785682B (en) 1979-09-26

Similar Documents

Publication Publication Date Title
BE870988A (fr) Composition pharmaceutique contenant de l'amoxycilline et du clavulanate de potassium
BE873973A (fr) Derives de metronidazole et compositions pharmaceutiques en contenant
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
LU81349A1 (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
IT7948392A0 (it) Apparecchio per ispezionare l'aspetto esterno di medicine solide
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
DZ206A1 (fr) Dérivés de l'indante et médicament qui en contiennent.
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
BE870403A (fr) Nouveaux 3-(2-hydroxy-4(substituant)-phenyl)-azacyclo-alcanes et medicament les contenant
TR20232A (tr) Cis-9-trikosen ve metomil'den olusan ensektisit bilesim
FR2610196B1 (fr) Clavulanate de potassium, procedes de preparation, compositions pharmaceutiques le contenant et utilisation comme agents antibacteriens
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
FR2460136B1 (fr) Compositions pharmaceutiques contenant des extraits de lierre grimpant
NZ191981A (en) Pharmaceutical composition containing amoxycillin and polyvinylpyrrolidone
FR2301244A1 (fr) Nouvelle preparation pharmaceutique contenant du glutamate ou de l'aspartate de magnesium
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
PH15663A (en) Antiphlogistic pharmaceutical compositions and method of use
BE866100A (fr) Derives de composes du type inter-phenylene-prostaglandine et compositions pharmaceutiques en contenant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: BEECHAM GROUP LTD

Effective date: 19981003